Organigram Global Down Over 14%, on Pace for Largest Percent Decrease Since February -- Data Talk

Dow Jones2025-12-24

Organigram Global Inc. (OGI.T) is currently at C$2.26, down C$0.39 or 14.58%

 

--Would be lowest close since Dec. 11, 2025, when it closed at C$2.26

--On pace for largest percent decrease since Feb. 11, 2025, when it fell 17.6%

--Currently down four consecutive days; down 22.24% over this period

--Longest losing streak since Dec. 9, 2025, when it fell for four straight trading days

--Worst four day stretch since the four days ending Feb. 14, 2025, when it fell 27.6%

--Down 1.1% month-to-date; on pace for worst month since Oct. 2025, when it fell 19.5%

--Down 1.96% year-to-date; on pace for worst year since 2023, when it fell 60.91%

--Down 94.74% from its all-time closing high of C$42.88 on May 17, 2019

--Up 0.22% from 52 weeks ago (Dec. 24, 2024), when it closed at C$2.25

--Down 22.24% from its 52-week closing high of C$2.90 on Dec. 17, 2025

--Up 77.56% from its 52-week closing low of C$1.27 on April 8, 2025

--Traded as low as C$2.24; lowest intraday level since Dec. 10, 2025, when it hit C$2.24

--Down 15.15% at today's intraday low; largest intraday percent decrease since Feb. 11, 2025, when it fell as much as 18.8%

 

All data as of 1:44:18 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 23, 2025 13:48 ET (18:48 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment